Prostatype Genomics AB (publ) PROGEN.ST Stock
0.02 SEK
{{ price }}
-47.191013%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Diagnostics & Research
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
23.28M SEK
LOW - HIGH [24H]
0.01
-
0.04 SEK
VOLUME [24H]
70.08M SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.35 SEK
Prostatype Genomics AB (publ) Price Chart
Prostatype Genomics AB (publ) PROGEN.ST Financial and Trading Overview
| Prostatype Genomics AB (publ) stock price | 0.02 SEK |
| Previous Close | 0.51 SEK |
| Open | 0.5 SEK |
| Bid | 0.53 SEK x N/A |
| Ask | 0.56 SEK x N/A |
| Day's Range | 0.5 - 0.57 SEK |
| 52 Week Range | 0.25 - 3.93 SEK |
| Volume | 154.82K SEK |
| Avg. Volume | 357.96K SEK |
| Market Cap | 66.9M SEK |
| Beta (5Y Monthly) | 0.933987 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.35 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.9 SEK |
PROGEN.ST Valuation Measures
| Enterprise Value | 11.49M SEK |
| Trailing P/E | N/A |
| Forward P/E | -5.6 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 82.211555 |
| Price/Book (mrq) | 0.6982544 |
| Enterprise Value/Revenue | 14.118 |
| Enterprise Value/EBITDA | -0.372 |
Trading Information
Prostatype Genomics AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.933987 |
| 52-Week Change | -85.50% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.93 SEK |
| 52 Week Low | 0.25 SEK |
| 50-Day Moving Average | 0.48 SEK |
| 200-Day Moving Average | 1.51 SEK |
PROGEN.ST Share Statistics
| Avg. Volume (3 month) | 357.96K SEK |
| Avg. Daily Volume (10-Days) | 447.22K SEK |
| Shares Outstanding | 119.46M |
| Float | 22.61M |
| Short Ratio | N/A |
| % Held by Insiders | 15.00% |
| % Held by Institutions | 13.47% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3803.11% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.82% |
| Return on Equity (ttm) | -128.73% |
Income Statement
| Revenue (ttm) | 813.73K SEK |
| Revenue Per Share (ttm) | 0.04 SEK |
| Quarterly Revenue Growth (yoy) | 50.20% |
| Gross Profit (ttm) | -12806086 SEK |
| EBITDA | -30916224 SEK |
| Net Income Avi to Common (ttm) | -31341608 SEK |
| Diluted EPS (ttm) | -0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.17M SEK |
| Total Cash Per Share (mrq) | 0.1 SEK |
| Total Debt (mrq) | 766.42K SEK |
| Total Debt/Equity (mrq) | 4.18 SEK |
| Current Ratio (mrq) | 1.093 |
| Book Value Per Share (mrq) | 0.802 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31038220 SEK |
| Levered Free Cash Flow (ttm) | -17506356 SEK |
Profile of Prostatype Genomics AB (publ)
| Country | Sweden |
| State | N/A |
| City | Solna |
| Address | Gustaf III:s Boulevard 34 |
| ZIP | 169 73 |
| Phone | 46 08 20 87 00 |
| Website | https://www.prostatypegenomics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 6 |
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The company's test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. Prostatype Genomics AB (publ) was incorporated in 2007 and is based in Solna, Sweden.
Q&A For Prostatype Genomics AB (publ) Stock
What is a current PROGEN.ST stock price?
Prostatype Genomics AB (publ) PROGEN.ST stock price today per share is 0.02 SEK.
How to purchase Prostatype Genomics AB (publ) stock?
You can buy PROGEN.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Prostatype Genomics AB (publ)?
The stock symbol or ticker of Prostatype Genomics AB (publ) is PROGEN.ST.
Which industry does the Prostatype Genomics AB (publ) company belong to?
The Prostatype Genomics AB (publ) industry is Diagnostics & Research.
How many shares does Prostatype Genomics AB (publ) have in circulation?
The max supply of Prostatype Genomics AB (publ) shares is 990.81M.
What is Prostatype Genomics AB (publ) Price to Earnings Ratio (PE Ratio)?
Prostatype Genomics AB (publ) PE Ratio is now.
What was Prostatype Genomics AB (publ) earnings per share over the trailing 12 months (TTM)?
Prostatype Genomics AB (publ) EPS is -0.35 SEK over the trailing 12 months.
Which sector does the Prostatype Genomics AB (publ) company belong to?
The Prostatype Genomics AB (publ) sector is Healthcare.
Prostatype Genomics AB (publ) PROGEN.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North All-Share EUR FIRSTNORTHEUR | 101.73 EUR 111.2 USD |
-1.09
|
— — | 101.46 EUR 110.91 USD | 103.05 EUR 112.65 USD | — - | — — |
| First North Sweden SEK PI FNSESEKPI | 1850.16 SEK 180.6 USD |
-1.05
|
— — | 1846.86 SEK 180.28 USD | 1872.89 SEK 182.82 USD | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1526.6 EUR 1668.78 USD |
-1.16
|
— — | 1522.28 EUR 1664.06 USD | 1548.19 EUR 1692.38 USD | — - | — — |
| First North Health Care PI FN20PI | 938.08 EUR 1025.45 USD |
-1.59
|
— — | 934.39 EUR 1021.42 USD | 959.34 EUR 1048.69 USD | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 124.63 SEK 12.17 USD |
-0.98
|
— — | 124.43 SEK 12.15 USD | 126.01 SEK 12.3 USD | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 101.79 DKK 14.92 USD |
-1.08
|
— — | 101.52 DKK 14.89 USD | 103.1 DKK 15.12 USD | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1978.51 SEK 193.13 USD |
-1.05
|
— — | 1974.98 SEK 192.78 USD | 2002.82 SEK 195.5 USD | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1632.46 EUR 1784.5 USD |
-1.16
|
— — | 1627.85 EUR 1779.46 USD | 1655.55 EUR 1809.74 USD | — - | — — |
| First North Health Care GI FN20GI | 942.4 EUR 1030.17 USD |
-1.59
|
— — | 938.69 EUR 1026.12 USD | 963.75 EUR 1053.51 USD | — - | — — |
- {{ link.label }} {{link}}